Choosing a Route of Administration for Quadrivalent Meningococcal Polysaccharide Vaccine: Intramuscular versus Subcutaneous
Open Access
- 1 January 2001
- journal article
- clinical trial
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 32 (1) , 170-172
- https://doi.org/10.1086/317553
Abstract
A clinical trial was conducted to compare intramuscular (im) with subcutaneous (sc) routes for administration of quadrivalent meningococcal polysaccharide vaccine in 141 adults. Safety assessment showed the im route had reduced erythema ( P < .01) and reduced headache on days 1 and 2 ( P < .05). Serological testing for serum bactericidal antibody titers against capsular groups A and C did not detect significant differences.Keywords
This publication has 3 references indexed in Scilit:
- Meningococcal Disease in College StudentsClinical Infectious Diseases, 1999
- Risk of meningococcal infection in college students.JAMA, 1999
- Clinical Efficacy of Meningococcus Group A Capsular Polysaccharide Vaccine in Children Three Months to Five Years of AgeNew England Journal of Medicine, 1977